Latest News

Bausch + Lomb announces the rollout of additional prescription parameters for the popular daily disposable Biotrue ONEday for Astigmatism contact lenses.

MiSight 1 day is a new lens developed by Coopervision. It hit the U.S. market in the spring of 2020 and is the first contact lens of its kind, receiving official approval from the FDA to not only provide vision correction but also to slow down the progression of childhood myopia.

MiSight lenses with omafilcon A are daily disposable and single-wear contact lenses indicated for the correction of myopic ametropia. With the FDA approval, they are also indicated for slowing the progression of myopia in children with non-diseased eyes requiring refractive vision correction in the range of -0.75D to -4.00D diopters and up to 0.75 diopters of astigmatism.

Johnson & Johnson Vision Care launches a new product within the ACUVUE brand name. ACUVUE RevitaLens is the first multi-purpose disinfecting contact lens solution (MPDS) carrying the ACUVUE brand name and marks the first time the brand name is assigned to a product other than a contact lens.
ACUVUE RevitaLens provides disinfection and all-day comfort to patients using non-daily disposable contact lenses such as bi-weekly or monthly replaceable lenses. The product utilizes a dual-disinfecting chemical that is gentle on the eyes but gets rid of harmful germs, deposits, and bacteria. It is available from major retailers and from eye care professionals.